Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

An upgrade for patient compliance
July 2016
SHARING OPTIONS:

RESEARCH TRIANGLE PARK, N.C.—Cenduit, a joint venture between Thermo Fisher Scientific and Quintiles, has expanded its portfolio with the launch of its upgraded Patient Reminders tool, which features include a two-way messaging dashboard and a mobile app available for iOS and Android devices, meant to boost patient compliance and engagement without increasing site or sponsor burdens. Patient Reminders can be integrated with existing Interactive Response Technology systems or used as a standalone service.
 
“Patient compliance is key to the success of any clinical trial. With our Patient Reminders tool, sponsors can have more control of their clinical trials and reduce patient dropout, which saves them time and money while increasing the quality of a trial’s endpoint data,” commented Chris Dailey, global head of technology at Cenduit. “With new features, the upgraded tool gives sponsors a simple means to keep patients engaged in their trials by communicating in real time through the two-way messaging dashboard.”

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.